Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Konrad H Bleicher

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Medicinal Chemistry|December 10, 2002
Chemogenomics: bridging a drug discovery gapKonrad H Bleicher
Nature Reviews. Drug Discovery|May 17, 2003
Hit and lead generation: beyond high-throughput screeningKonrad H Bleicher, Hans-Joachim Böhm, Klaus Müller, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2002
Parallel solution- and solid-phase synthesis of spiropyrrolo-pyrroles as novel neurokinin receptor ligandsKonrad H Bleicher, Yves Wüthrich, Geo Adam, et al.
Current Opinion in Chemical Biology|June 9, 2004
Ligand identification for G-protein-coupled receptors: a lead generation perspectiveKonrad H Bleicher, Luke G Green, Rainer E Martin, et al.
Angewandte Chemie (International Ed. in English)|March 10, 2018
Functionalized Proline-Rich Peptides Bind the Bacterial Second Messenger c-di-GMPCarlotta Foletti, Rolf A Kramer, Harald Mauser, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2002
Parallel solution- and solid-phase synthesis of spirohydantoin derivatives as neurokinin-1 receptor ligandsKonrad H Bleicher, Yves Wüthrich, Maxime De Boni, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2010
Discovery of novel and orally active FXR agonists for the potential treatment of dyslipidemia & diabetesHans G F Richter, Gregory M Benson, Denise Blum, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Medicinal Chemistry|December 10, 2002
Chemogenomics: bridging a drug discovery gapKonrad H Bleicher
Nature Reviews. Drug Discovery|May 17, 2003
Hit and lead generation: beyond high-throughput screeningKonrad H Bleicher, Hans-Joachim Böhm, Klaus Müller, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2002
Parallel solution- and solid-phase synthesis of spiropyrrolo-pyrroles as novel neurokinin receptor ligandsKonrad H Bleicher, Yves Wüthrich, Geo Adam, et al.
Current Opinion in Chemical Biology|June 9, 2004
Ligand identification for G-protein-coupled receptors: a lead generation perspectiveKonrad H Bleicher, Luke G Green, Rainer E Martin, et al.
Angewandte Chemie (International Ed. in English)|March 10, 2018
Functionalized Proline-Rich Peptides Bind the Bacterial Second Messenger c-di-GMPCarlotta Foletti, Rolf A Kramer, Harald Mauser, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2002
Parallel solution- and solid-phase synthesis of spirohydantoin derivatives as neurokinin-1 receptor ligandsKonrad H Bleicher, Yves Wüthrich, Maxime De Boni, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2010
Discovery of novel and orally active FXR agonists for the potential treatment of dyslipidemia & diabetesHans G F Richter, Gregory M Benson, Denise Blum, et al.
Pageof 1